Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
estriol (1 trial)
glatiramer acetate (copaxone) (1 trial)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Sclerosis (Phase 2)
Trials (1 total)
Trial APIs (2 total)